Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BioSpecifics Technologies Corp. Company Profile (NASDAQ:BSTC)

Consensus Ratings for BioSpecifics Technologies Corp. (NASDAQ:BSTC) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $38.00 (5.26% downside)

Analysts' Ratings History for BioSpecifics Technologies Corp. (NASDAQ:BSTC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/12/2014MKM PartnersBoost Price TargetBuy$28.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
1/9/2014MKM PartnersBoost Price TargetBuy$24.50 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
12/9/2013MKM PartnersBoost Price TargetBuy$23.50 -> $24.50ViewTweet This Rating  Share This Rating on StockTwits
11/13/2013MKM PartnersBoost Price TargetBuy$21.00 -> $23.50ViewTweet This Rating  Share This Rating on StockTwits
10/22/2013JMP SecuritiesInitiated CoverageOutperform$28.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013MKM PartnersLower Price TargetBuy$21.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2013AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/24/2012 forward)
Discuss BioSpecifics Technologies Corp.